Stocks
Scilex Holding CompanySCLX
NASDAQHealthcareBiotechnology$2.35
Price as of · delayed, not real-time
A commercial-stage biopharmaceutical company focused on developing and commercializing non-opioid pain management products, including its lead product ZTlido for postherpetic neuralgia. Investors track the stock for its pipeline of late-stage pain therapies and its connection to Sorrento Therapeutics, its former parent company.
52W Range: $2.27-$16.81
Congressional Interest in Scilex Holding Company (SCLX)
No congressional trades have been disclosed for Scilex Holding Company (SCLX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading SCLX?
No congressional trades found for this stock.